OABIW
OmniAb, Inc.Company Information
- Company Name
- OmniAb, Inc.
- CIK
- CIK0001846253
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- OABIW: Nasdaq, OABI: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8731
- SIC Description
- Services-Commercial Physical & Biological Research
- Ticker
- OABIW
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-11-07
- Last sale
- 2026-04-07
- Shares purchased (TTM)
- 161,038
- Shares sold (TTM)
- 197,129
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 59,481,593
- Shares outstanding
- 128,795,000
- Ownership
- 46.18%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 24 | 29 | 26 | 29 | 18 | 11 | 28 | 27 | 21 | 19 | 16 | 21 | ||||||
| Available For Sale Securities Debt Securities Current | 28 | 20 | 29 | 31 | 23 | 33 | 32 | 32 | 36 | 50 | 71 | 75 | ||||||
| Accounts Receivable Net Current | 10 | 13 | 7 | 3 | 3 | 6 | 5 | 3 | 7 | 4 | 4 | 6 | ||||||
| Prepaid Expense And Other Assets Current | 4 | 3 | 4 | 4 | 3 | 4 | 3 | 4 | 3 | 4 | 4 | 4 | ||||||
| Assets Current | 66 | 65 | 65 | 66 | 48 | 54 | 68 | 67 | 67 | 77 | 95 | 107 | ||||||
| Intangible Assets Net Excluding Goodwill | 116 | 119 | 125 | 128 | 132 | 135 | 138 | 144 | 148 | 152 | 155 | 159 | ||||||
| Goodwill | 84 | 84 | 84 | 84 | 84 | 84 | 84 | 84 | 84 | 84 | 84 | 84 | ||||||
| Property Plant And Equipment Net | 8 | 9 | 9 | 13 | 14 | 15 | 15 | 16 | 17 | 18 | 18 | 19 | ||||||
| Operating Lease Right Of Use Asset | 14 | 15 | 16 | 16 | 17 | 17 | 18 | 18 | 19 | 19 | 20 | 20 | ||||||
| Restricted Cash Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | ||||||
| Restricted Cash Equivalents Noncurrent | - | - | - | - | - | - | - | - | - | - | 1 | - | ||||||
| Other Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | ||||||
| Assets | 290 | 294 | 301 | 310 | 296 | 306 | 326 | 332 | 337 | 353 | 375 | 392 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 4 | 3 | ||||||
| Accrued Liabilities Current | 4 | 4 | 6 | 5 | 5 | 4 | 6 | 5 | 5 | 4 | 7 | 7 | ||||||
| Taxes Payable Current | - | - | - | - | - | - | - | - | - | - | 0 | 3 | ||||||
| Business Combination Contingent Consideration Liability Current | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 2 | ||||||
| Contract With Customer Liability Current | 2 | 3 | 3 | 2 | 1 | 2 | 2 | 3 | 3 | 6 | 7 | 7 | ||||||
| Operating Lease Liability Current | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | ||||||
| Liabilities Current | 14 | 14 | 16 | 13 | 13 | 11 | 15 | 14 | 14 | 18 | 23 | 25 | ||||||
| Business Combination Contingent Consideration Liability Noncurrent | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 3 | 3 | 4 | ||||||
| Deferred Income Tax Liabilities Net | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 4 | 7 | 9 | 11 | 14 | ||||||
| Operating Lease Liability Noncurrent | 15 | 16 | 16 | 17 | 18 | 19 | 19 | 20 | 21 | 21 | 22 | 23 | ||||||
| Contract With Customer Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 30 | 31 | 34 | 32 | 34 | 33 | 38 | 40 | 43 | 51 | 61 | 67 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 440 | 437 | 433 | 429 | 398 | 393 | 389 | 380 | 366 | 360 | 354 | 350 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | -0 | 0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -180 | -174 | -166 | -152 | -135 | -120 | -101 | -88 | -72 | -58 | -39 | -25 | ||||||
| Stockholders Equity | 260 | 263 | 267 | 277 | 262 | 274 | 288 | 292 | 294 | 301 | 315 | 325 | ||||||
| Liabilities And Stockholders Equity | 290 | 294 | 301 | 310 | 296 | 306 | 326 | 332 | 337 | 353 | 375 | 392 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | ||||||
| Common Stock Shares Issued | 145 | 145 | 144 | 144 | 123 | 122 | 122 | 120 | 118 | 117 | 117 | 116 | ||||||
| Shares Outstanding | 145 | 145 | 144 | 144 | 123 | 122 | 122 | 120 | 118 | 117 | 117 | 116 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialOmniAb, Inc. (OABIW) — SEC Financial Statements & Analysis
OmniAb, Inc. (OABIW) is a services-commercial physical & biological research company, incorporated in DE. OmniAb, Inc. trades on Nasdaq as: OABIW, OABI. OmniAb, Inc. (OABIW)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, On profitability, OmniAb, Inc. posts a gross margin of 98.28%, an operating margin of -125.78%, a net margin of -115.12%, a Return on Equity (ROE) of -16.95%, a Return on Assets (ROA) of -15.11%, and a Return on Invested Capital (ROIC) of -20.16%. Per share, it reports EPS of $-0.34, diluted EPS of $-0.34, free cash flow per share of $-0.14, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 67.01% year-over-year, net income growth of -30.30% year-over-year, and EPS growth of -42.56% year-over-year. On the balance sheet, it maintains a current ratio of 4.80x, a quick ratio of 4.53x, working capital of $52.26M, a debt-to-equity ratio of 0.12x, a debt ratio of 0.1, free cash flow of $-18.14M (TTM), and net debt of $-24.90M. Figures sourced from SEC EDGAR.
- EPS TTM
- $-0.34
- ROE TTM
- -16.95%
- ROA TTM
- -15.11%
- Debt To Equity
- 0.12x
- Free Cash Flow TTM
- $-18.14M
- Net Revenue TTM Growth 1Y
- 67.01%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is OmniAb, Inc. in?
OmniAb, Inc. (OABIW) operates in the Services-Commercial Physical & Biological Research industry.
What exchange does OABIW trade on?
OmniAb, Inc. (OABIW) trades on the Nasdaq.
Where is OmniAb, Inc. incorporated?
OmniAb, Inc. is incorporated in DE.
When was OmniAb, Inc. (OABIW)'s most recent SEC filing?
OmniAb, Inc. (OABIW)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is OABIW's EPS (earnings per share)?
OmniAb, Inc. (OABIW)'s trailing twelve month EPS is $-0.34 as of 2026-06-30.
What is OABIW's ROE (return on equity)?
OmniAb, Inc. (OABIW)'s trailing twelve month Return on Equity (ROE) is -16.95% as of 2026-06-30.
What is OABIW's ROA (return on assets)?
OmniAb, Inc. (OABIW)'s trailing twelve month Return on Assets (ROA) is -15.11% as of 2026-06-30.
What is OABIW's ROIC (return on invested capital)?
OmniAb, Inc. (OABIW)'s trailing twelve month Return on Invested Capital (ROIC) is -20.16% as of 2026-06-30.